Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells

Relevance to the pathogenesis of myelodysplastic syndrome

Norihiro Awaya, Hideo Uchida, Yoshitaka Miyakawa, Kentaro Kinjo, Hiromichi Matsushita, Hideaki Nakajima, Yasuo Ikeda, Masahiro Kizaki

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Recent studies have shown that point mutations in granulocyte colony-stimulating factor receptor (G-CSFR) are involved in the pathogenesis of severe congenital neutropenia (SCN) and in the transformation of SCN to acute myelogenous leukemia (AML). It is reasonably speculated that the abnormalities in the signal transduction pathways for G-CSF could be partly responsible for the pathogenesis and the development to AML in patients with myelodysplastic syndromes (MDS). Therefore, we investigated the structural and functional abnormalities of the G-CSFR in 14 patients with MDS and 10 normal subjects. In in vitro colony forming assay, MDS samples showed reduced response to growth factors. However, G-CSF, but not GM-CSF and IL-3, enhanced clonal growth in three cases of high risk patients with MDS (RAEB, RAEB-t, and MDS having progressed to acute myeloid leukemia (AML)) and one low risk patient (RA). Eight out of 14 patients including above 4 patients demonstrated a common deletion of the G-CSFR cDNA; a deletion of three nucleotides (2128-2130) in the juxtamembrane domain of the G-CSFR, which resulted in a conversion of Asn630 Arg631 to Lys630. To assess the functional activities of this deletion in the G-CSFR isoform, a mutant with the same three-nucleotide deletion was constructed by site-directed mutagenesis. FDCP-2 cells expressing the G-CSFR isoform responded to G-CSF, and exhibited proliferative responses than did those cells having wild-type G-CSFR. Moreover, these isoforms showed prolonged activation of STAT3 in response to G-CSF than did the wild-type. These results suggest that the deletion in the juxtamembrane domain of the G-CSFR gives a growth advantage to abnormal MDS clones and may contribute to the pathogenesis of MDS.

Original languageEnglish
Pages (from-to)327-335
Number of pages9
JournalJournal of Cellular Physiology
Volume191
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

Granulocyte Colony-Stimulating Factor Receptors
Myelodysplastic Syndromes
Protein Isoforms
Granulocyte Colony-Stimulating Factor
Acute Myeloid Leukemia
Refractory Anemia with Excess of Blasts
Granulocyte-Macrophage Colony-Stimulating Factor
Nucleotides
Signal transduction
Mutagenesis
Interleukin-3
Growth
Site-Directed Mutagenesis
Point Mutation
Assays
Signal Transduction
Intercellular Signaling Peptides and Proteins
Complementary DNA
Clone Cells
Chemical activation

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells : Relevance to the pathogenesis of myelodysplastic syndrome. / Awaya, Norihiro; Uchida, Hideo; Miyakawa, Yoshitaka; Kinjo, Kentaro; Matsushita, Hiromichi; Nakajima, Hideaki; Ikeda, Yasuo; Kizaki, Masahiro.

In: Journal of Cellular Physiology, Vol. 191, No. 3, 2002, p. 327-335.

Research output: Contribution to journalArticle

Awaya, Norihiro ; Uchida, Hideo ; Miyakawa, Yoshitaka ; Kinjo, Kentaro ; Matsushita, Hiromichi ; Nakajima, Hideaki ; Ikeda, Yasuo ; Kizaki, Masahiro. / Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells : Relevance to the pathogenesis of myelodysplastic syndrome. In: Journal of Cellular Physiology. 2002 ; Vol. 191, No. 3. pp. 327-335.
@article{50f530943f364350a2c87d659600ba61,
title = "Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: Relevance to the pathogenesis of myelodysplastic syndrome",
abstract = "Recent studies have shown that point mutations in granulocyte colony-stimulating factor receptor (G-CSFR) are involved in the pathogenesis of severe congenital neutropenia (SCN) and in the transformation of SCN to acute myelogenous leukemia (AML). It is reasonably speculated that the abnormalities in the signal transduction pathways for G-CSF could be partly responsible for the pathogenesis and the development to AML in patients with myelodysplastic syndromes (MDS). Therefore, we investigated the structural and functional abnormalities of the G-CSFR in 14 patients with MDS and 10 normal subjects. In in vitro colony forming assay, MDS samples showed reduced response to growth factors. However, G-CSF, but not GM-CSF and IL-3, enhanced clonal growth in three cases of high risk patients with MDS (RAEB, RAEB-t, and MDS having progressed to acute myeloid leukemia (AML)) and one low risk patient (RA). Eight out of 14 patients including above 4 patients demonstrated a common deletion of the G-CSFR cDNA; a deletion of three nucleotides (2128-2130) in the juxtamembrane domain of the G-CSFR, which resulted in a conversion of Asn630 Arg631 to Lys630. To assess the functional activities of this deletion in the G-CSFR isoform, a mutant with the same three-nucleotide deletion was constructed by site-directed mutagenesis. FDCP-2 cells expressing the G-CSFR isoform responded to G-CSF, and exhibited proliferative responses than did those cells having wild-type G-CSFR. Moreover, these isoforms showed prolonged activation of STAT3 in response to G-CSF than did the wild-type. These results suggest that the deletion in the juxtamembrane domain of the G-CSFR gives a growth advantage to abnormal MDS clones and may contribute to the pathogenesis of MDS.",
author = "Norihiro Awaya and Hideo Uchida and Yoshitaka Miyakawa and Kentaro Kinjo and Hiromichi Matsushita and Hideaki Nakajima and Yasuo Ikeda and Masahiro Kizaki",
year = "2002",
doi = "10.1002/jcp.10102",
language = "English",
volume = "191",
pages = "327--335",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells

T2 - Relevance to the pathogenesis of myelodysplastic syndrome

AU - Awaya, Norihiro

AU - Uchida, Hideo

AU - Miyakawa, Yoshitaka

AU - Kinjo, Kentaro

AU - Matsushita, Hiromichi

AU - Nakajima, Hideaki

AU - Ikeda, Yasuo

AU - Kizaki, Masahiro

PY - 2002

Y1 - 2002

N2 - Recent studies have shown that point mutations in granulocyte colony-stimulating factor receptor (G-CSFR) are involved in the pathogenesis of severe congenital neutropenia (SCN) and in the transformation of SCN to acute myelogenous leukemia (AML). It is reasonably speculated that the abnormalities in the signal transduction pathways for G-CSF could be partly responsible for the pathogenesis and the development to AML in patients with myelodysplastic syndromes (MDS). Therefore, we investigated the structural and functional abnormalities of the G-CSFR in 14 patients with MDS and 10 normal subjects. In in vitro colony forming assay, MDS samples showed reduced response to growth factors. However, G-CSF, but not GM-CSF and IL-3, enhanced clonal growth in three cases of high risk patients with MDS (RAEB, RAEB-t, and MDS having progressed to acute myeloid leukemia (AML)) and one low risk patient (RA). Eight out of 14 patients including above 4 patients demonstrated a common deletion of the G-CSFR cDNA; a deletion of three nucleotides (2128-2130) in the juxtamembrane domain of the G-CSFR, which resulted in a conversion of Asn630 Arg631 to Lys630. To assess the functional activities of this deletion in the G-CSFR isoform, a mutant with the same three-nucleotide deletion was constructed by site-directed mutagenesis. FDCP-2 cells expressing the G-CSFR isoform responded to G-CSF, and exhibited proliferative responses than did those cells having wild-type G-CSFR. Moreover, these isoforms showed prolonged activation of STAT3 in response to G-CSF than did the wild-type. These results suggest that the deletion in the juxtamembrane domain of the G-CSFR gives a growth advantage to abnormal MDS clones and may contribute to the pathogenesis of MDS.

AB - Recent studies have shown that point mutations in granulocyte colony-stimulating factor receptor (G-CSFR) are involved in the pathogenesis of severe congenital neutropenia (SCN) and in the transformation of SCN to acute myelogenous leukemia (AML). It is reasonably speculated that the abnormalities in the signal transduction pathways for G-CSF could be partly responsible for the pathogenesis and the development to AML in patients with myelodysplastic syndromes (MDS). Therefore, we investigated the structural and functional abnormalities of the G-CSFR in 14 patients with MDS and 10 normal subjects. In in vitro colony forming assay, MDS samples showed reduced response to growth factors. However, G-CSF, but not GM-CSF and IL-3, enhanced clonal growth in three cases of high risk patients with MDS (RAEB, RAEB-t, and MDS having progressed to acute myeloid leukemia (AML)) and one low risk patient (RA). Eight out of 14 patients including above 4 patients demonstrated a common deletion of the G-CSFR cDNA; a deletion of three nucleotides (2128-2130) in the juxtamembrane domain of the G-CSFR, which resulted in a conversion of Asn630 Arg631 to Lys630. To assess the functional activities of this deletion in the G-CSFR isoform, a mutant with the same three-nucleotide deletion was constructed by site-directed mutagenesis. FDCP-2 cells expressing the G-CSFR isoform responded to G-CSF, and exhibited proliferative responses than did those cells having wild-type G-CSFR. Moreover, these isoforms showed prolonged activation of STAT3 in response to G-CSF than did the wild-type. These results suggest that the deletion in the juxtamembrane domain of the G-CSFR gives a growth advantage to abnormal MDS clones and may contribute to the pathogenesis of MDS.

UR - http://www.scopus.com/inward/record.url?scp=0036242062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036242062&partnerID=8YFLogxK

U2 - 10.1002/jcp.10102

DO - 10.1002/jcp.10102

M3 - Article

VL - 191

SP - 327

EP - 335

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 3

ER -